IKT vs BGIN Comparison

Inhibikase Therapeutics Inc a clinical-stage pharmaceutical company developing therapeutics to modify the course of cardiopulmonary diseases, namely, Pulmonary Arterial Hypertension (PAH), in which aberrant signaling through type III receptor tyrosine kinases, including platelet derived growth factor receptors and a stem cell factor receptor, known as c-Kit, has been implicated. Its product candidate is IKT-001, a prodrug of imatinib mesylate (imatinib), for PAH which is an orphan indication. The company has developed its own portfolio of protein kinase inhibitors to treat bacterial and viral infections, including viral infections in the brain. It has one reporting segment, which is the business of developing protein kinase inhibitor therapeutics.

BGIN Blockchain Ltd is a digital asset technology company engaged in cryptocurrency mining technologies, self-mining operations, and the design and sale of ASIC mining machines. The company develops proprietary mining hardware under its ICERIVER brand and provides mining infrastructure and hosting solutions. It operates through two reportable segments: cryptocurrency mining and sale of mining machines. The company focuses on cryptocurrencies such as Bitcoin, Dogecoin, KAS, ALPH, and RXD. Geographically, it derives revenue from Hong Kong, China, Vietnam, the United States, Singapore, and other markets.